Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries
This article, published in PLoS ONE, discusses the estimated economic impact of implementing comprehensive human papillomavirus (HPV) screening and prevention programs in low- and middle-income countries. The authors performed a modeling analysis to estimate possible financial costs of two-dose HPV vaccination for girls aged 10 years, as well as cervical cancer screening, HPV cytology, and preventive treatment for women aged 30 to 49 years in 102 low- and middle-income countries from 2015 to 2024. The findings suggest that while vaccine price per dose would have substantial impact in middle-income countries ineligible for assistance from Gavi, the Vaccine Alliance, and replacing routine cytology with HPV-based screening may reduce total costs, further data on the health impact and relative cost-effectiveness of strategies are needed to determine the best value for public health dollars.
Author: Campos NG, Sharma M, Clark A, Kim JJ, Resch SC
» Visit web page (English)
(Located at journals.plos.org)
Citation: Campos NG, Sharma M, Clark A, Kim JJ, Resch SC. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries. PLoS ONE. 2016;11(10):e0164000.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)